Projects

Search from 1167 projects:

Reset RSS

Time frame

Year

Year To

Project type

Project status

Unit

Recruitment

Labels

4 Project(s)

Apr 17, 2024

A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction and high immune responsiveness (MO30039/MO43340)– The DANTE Trial A Trial of AIO in collaboration with SAKK

Apr 17, 2024

Clinical Studies - Apr 17, 2024 - Dec 31, 2028

Ongoing

Project leader: Weisshaupt Christian
Members: Müller Fiona, Kehl Jeanine

Nov 16, 2022

An open-label, mulit-center, phase II platform study evaluating the efficacy and safety of NIS793 and other new investigational drug com-binations with standard of care (SOC) anti-cancer therapy for the second line treatment of metastatic colorectal cancer (mCRC)

Nov 16, 2022

Das Ziel dieser Studie ist es herauszufinden, ob die Zuga-be der Prüfsubstanz NIS793 allein oder in Kombination mit einem Medikament namens Tislelizumab zur Standard-Krebstherapie möglicherweise Behandlungen von meta-stasiertem kolorektalem Karzinom...

Clinical Studies - Nov 16, 2022 - Mar 31, 2025

Ongoing

Project leader: Weisshaupt Christian
Members: Aeschbacher Anette

Nov 8, 2022

IP-001_RFA (IP-IIO-622): Intratumoral injection of IP-001 following thermal ablation in patients with advanced solid tumors. A multicenter Phase 1b/2a trial in colorectal cancer, non-small cell lung cancer, and soft tissue sarcoma patients

Nov 8, 2022

Diese Studie untersucht die Sicherheit und erste Wirksamkeit einer immunstimulierenden thermischen Ablation in Kombination mit dem Prüfpräparat IP-001, welches nach der Ablation in den Tumor injiziert wird (intratumoral). Die thermische Ablation ist...

Clinical Studies - Nov 8, 2022 - Dec 31, 2024

Ongoing

Project leader: Jörger Markus
Members: Wittwer Yvonne, Quinter Janine

Jan 1, 2022

Low Anterior Resection Syndrome After Rectum Resection for Rectal Carcinoma. (LARS-Austria)

Jan 1, 2022

Primary objective of the LARS study is to obtain the LARS score before surgical rectal cancer treatment, after neoadjuvant therapy and during the standard follow-up after surgery. This study mainly serves to obtain statistical data for the incidence...

Clinical Studies - Jan 1, 2022 - Aug 30, 2026

Ongoing

Project leader: Presl Jaroslav, Brunner Walter